Results 81 to 90 of about 1,494 (190)

Safety and Efficacy of Adoptive Transfer of Stem Cell Memory Enriched Virus Specific T Cells against CMV and EBV

Advanced Science, Volume 13, Issue 9, 13 February 2026.
This study finds that CD8⁺ TSCM cells exhibit superior self‐renewal, differentiation, and antiviral activity. Transcriptome and epigenome analyses highlight MAPK cascade regulation in TSCM cells. In vivo, virus‐specific TSCM cells show enhanced persistence and tumor protection.
Xun‐Hong Cao, Xu‐Ying Pei, Yuan‐Yuan Zhang, Juan Xie, Jing‐Wei Tu, Zhuo‐Jun Liu, Yi‐Yang Ding, Chen‐Hua Yan, Yu‐Hong Chen, Yu Wang, Lan‐Ping Xu, Xiao‐Hui Zhang, Xiao‐Jun Huang, Xiang‐Yu Zhao   +13 more
wiley   +1 more source

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

Journal of Hematology & Oncology, 2018
Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a highly aggressive hematological malignancy with extremely poor outcome. The median overall survival for adult patients is 9–13 months.
Weili Sun, Huaying Liu, Young Kim, Nicole Karras, Anna Pawlowska, Debbie Toomey, Wade Kyono, Paul Gaynon, Joseph Rosenthal, Anthony Stein   +9 more
doaj   +1 more source

Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement [PDF]

, 2019
A 62-year-old male was diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN) with a MYC rearrangement. Four months after the first unrelated bone marrow transplantation (BMT), he developed the relapsed BPDCN.
Sakamoto, Kana, Kato, Takeharu, Takeuchi, Kengo, Makiyama, Junya, Fujioka, Machiko, Yoshida, Shinichiro, Miyazaki, Yasushi, Taguchi, Jun, Hata, Tomoko, Imaizumi, Yoshitaka, Itonaga, Hidehiro, Sawayama, Yasushi, Ohshima, Koichi, Taguchi, Masataka, Horai, Makiko, Niino, Daisuke   +15 more
core   +1 more source

Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients

eJHaem
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) predominantly occurs in adults ≥60 years old; 10–20% of cases are pediatric or adolescent/young adult (AYA) patients.
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S. Stein, Soheil Meshinchi, Craig A. Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I. Mughal, Anna B. Pawlowska   +11 more
doaj   +1 more source

Epidemiology and Survival Outcomes in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A US Population-Based Study

, 2023
Background: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, clinically aggressive hematological malignancy arising from plasmacytoid dendritic cell precursors.
Karki, Ujjwal, Poudel, Shyam K, Shah, Anish, Ghimire, Bipin, Budhathoki, Pravash, Muhsin Muhsin Chisti, Mohammad   +5 more
core  

Adult TWIST2‐high B‐ALL confirms metabolic association but reveals molecular heterogeneity

HemaSphere, Volume 10, Issue 6, June 2026.
Wencke Walter, Veronika Ecker, Wolfgang Kern, Anna Stengel   +3 more
wiley   +1 more source

Covalent Organic Frameworks for Photocatalysis

Advanced Materials, Volume 37, Issue 52, December 29, 2025.
This review provides an overview of recent advances in covalent organic frameworks (COFs) for photocatalysis, focusing on sustainable energy applications like water splitting, hydrogen peroxide generation, and CO2 and N2 reduction. It discusses design principles, structure‐function relationships, challenges in COF photocatalysis, and strategies to ...
Bikash Mishra, Akhtar Alam, Avanti Chakraborty, Bidhan Kumbhakar, Samrat Ghosh, Pradip Pachfule, Arne Thomas   +6 more
wiley   +1 more source

A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients

Therapeutic Advances in Hematology
Background: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological cancer. Due to its low incidence, researchers struggle to gather sufficient prospective data to inform clinical treatment.
Chen Gong, Ying Liu, Mingzhi Zhang
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN):Multi-Center Collaboration and Global Registry Program

, 2023
Background BPDCN is a rare, aggressive hematologic malignancy derived from the precursors of plasmacytoid dendritic cells (pDC), typically presenting with primary cutaneous dissemination and involvement of bone marrow (BM) as well as extramedullary sites
Attardi, Enrico, Voskanyan, Astghik, Peng, Ching-Tien, Ohannessian, Robin, Tamamyan, Gevorg, Michael, Michalis, Martelli, Maria Paola, Bedirian, Karen, Martirosyan, Nare, Abramashvili, Mariam, Kotoucek, Pavel P, Ivanyan, Arusyak, Kutluk, Tezer, Papyan, Ruzanna, Alencar, Alvaro J., Tekkesin, Funda, Al-Jadiry, Mazin Faisal, Ghali, Hasanein, Voso, Maria Teresa, Su, Min-Yu, Badikyan, Maria, El-Ashwah, Shaimaa, Danelyan, Samvel, Owen, Carolyn, Bakhshi, Sameer, Kebudi, Rejin, Pemmaraju, Naveen, Konopleva, Marina Y., Sergi, Consolato, Bardakhchyan, Samvel, Elashwah, Salma, Kazandjian, Dickran, Totogashvili, Nino, Elashwah, S, Alencar, AJ, Su, MY, Papyan, R, Tekkesin, F, Tamamyan, G, Bakhshi, S, Al-Jadiry, MF, Abramashvili, M, Ghali, H, Martelli, MP, Owen, C, Badikyan, M, Voskanyan, A, Pemmaraju, N, Bedirian, K, Totogashvili, N, Kotoucek, PP, Kebudi, R, Sergi, C, Kazandjian, D, Peng, CT, Attardi, E, Konopleva, MY, Ohannessian, R, Ivanyan, A, Danelyan, S, Martirosyan, N, Bardakhchyan, S, Voso, MT, El-Ashwah, S, Michael, M, Kutluk, T   +65 more
core   +1 more source

眼巩膜受侵母细胞性浆细胞样树突状细胞肿瘤1例并文献复习

Zhongguo shiyan zhenduanxue, 2017
母细胞性浆细胞样树突状细胞肿瘤（blastic plasmacytoid dendritic cell neoplasm,BPDCN）是一种罕见的血液系统恶性肿瘤,易侵犯皮肤和骨髓,目前的诊断还没有完全特征性的指标,治疗上亦无标准有效的治疗手段。BPDCN的发病以老年人居多,现总结我科收治的1例青年男性BPDCN患者临床资料,并结合国内外报道的BPDCN病例,回顾性分析患者的临床特征,提高临床医生对BPDCN的诊疗水平。1病例资料患者,男性,25岁 ...
刘芳, 朱耿军, 任立参, 沈卫章, 赵岩, 徐文   +5 more
doaj